If the bill were passed with its current language, medtech companies—many of which call Minnesota home—will avoid the 2.3 excise tax until 2023.
Health Care + Med Tech
Through the purchase, Medtronic will acquire products that provide doctors with an internal view of the esophagus during endoscopic and surgical procedures.
The deal remains contingent on Entellus shareholder approval, as well as regulatory approval.
State study projects a nearly 35 percent increase with employers likely picking up much of the tab.
Fundraising comes after positive pre-clinical results for its AnestaGel product.
Using OptumLab data, researchers found some anticoagulants are easier on kidneys.
The deal has widely been compared to CVS’s proposed merger with Atena—since both cases involve the increasingly blurred lines in the healthcare industry—as insurance companies become more involved in direct care.
The study’s lead researcher, Michael McAlpine, said the discovery could be a “game-changer” and lead to fewer medical errors during surgery.
On-site and near-site clinics, along with wellness programs, are producing good results for employees of Minnesota companies.
Edina, St. Louis Park and Bloomington passed similar ordinances earlier this year.
The new collaboration is seeking to develop a ‘microbiome’ drug for multiple sclerosis and rheumatoid arthritis.
Another study found that most employees with high-deductible health plans (HDHPs) aren’t comparison shopping for medical care.
There are 1.5 million office visits a year in the US for the treatment of urethral blockages, a market Urotronic hopes to tap with its new device.
The buyers, Altus Capital Partners, will pay a 25 percent premium of the stock.
The federal tax department claims the medical technology giant dodged higher taxes by attributing a majority share of its profits to its factories in Puerto Rico.
Most residents report having health insurance and say system is on “the right track.”
The method is aimed at those under 50 with hereditary high colorectal risk.
The company is developing tech to greatly boost accuracy of common flu and malaria tests.